Sponsor:
Ottawa Heart Institute Research Corporation
Code:
NCT06547788
Conditions
Mitral Regurgitation
Mitral Valve Disease
Heart Failure
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Mitral valve repair with creation of an 8 mm inter-atrial shunt
Brief summary:
Conditions
Mitral Regurgitation
Mitral Valve Disease
Heart Failure
Study ID
NCT06547788
Start date
Dec 19, 2024
Status verified date
Nov, 2026
Completion date
Jan 31, 2030
Anticipated
Primary completion date
Jan 31, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
50 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
experimental: Mitral valve repair with creation of an 8m inter-atrial shunt
active comparator: Mitral valve repair without a shunt
Interventions
Mitral valve repair with creation of an 8 mm inter-atrial shunt
Primary outcome measure
Central contacts
Locations
University of Ottawa Heart Institute
Recruiting
Ottawa, Ontario, Canada, K1Y 4W7
Contacts
Kenza Rahmouni, Dr.
krahmouni@ottawaheart.caSponsor
Ottawa Heart Institute Research Corporation
Last update posted
Nov 5, 2026
Last verified
Nov, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-06. This information was provided to ClinicalTrials.gov by Ottawa Heart Institute Research Corporation on 2026-11-05. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.